A venture backed medical device company, is investigating minimally invasive technology intended to transform the treatment of mitral regurgitation. The company has an exclusive worldwide license to the technology and is currently working on additional minimally invasive technologies for the treatment of structural heart disease.
"There is a compelling need for less invasive mitral repair technologies."
"NeoChord has developed a mitral valve repair technology that may offer MR patients the choice of a minimally invasive procedure over the current standard-of-care: open-chest surgery on a stopped heart" says Giovanni Speziali, M.D., Cardiac Surgeon and primary inventor of the Neochord Device.
- Click to Learn More -